© 2015 Elsevier B.V. A selection of 289 pyrimidine derivatives with anti-HIV RT activities as non-nucleoside HIV RT inhibitors (NNRTI) were studied. The associative neural network (ASNN) method was applied to develop a quantitative structure-activity relationship (QSAR) for anti-HIV RT activity. The calculated models were validated using the bagging approach. A consensus model with R2=0.87 and RMSE=0.5 was obtained from 10 individual models. Scaffold analysis and molecular docking of the compounds used in the QSAR model identified a potential chemical scaffold. The results showed that scaffold-based analysis of the QSAR model could be helpful in identifying potent scaffolds for further exploration than analyzing the overall model. Matched m...
In this work we report a parallel application of both docking- and shape-based virtual screening (VS...
Human immunodeficiency virus (HIV) is the primary infectious agent of acquired immunodeficiency synd...
AbstractDue to the AIDS crisis, development of new, selective and safe non-nucleoside reverse transc...
A selection of 289 pyrimidine derivatives with anti-HIV RT activities as non-nucleoside HIV RT inhib...
© 2015 Elsevier B.V. A selection of 289 pyrimidine derivatives with anti-HIV RT activities as non-nu...
The Acquired Immunodeficiency Syndrome (AIDS) is one the most fatal disorders for which there have b...
Diarylpyrimidines (DAPYs), acting as HIV-1 nonnucleoside reverse transcriptase inhibitors (NNRTIs), ...
There has been a tremendous progress in the development of anti-HIV therapies since the discovery of...
1484-1493Seven novel lead compounds, acting as NNRTIs of HIV-1, are extracted from a database of, in...
Seven novel lead compounds, acting as NNRTIs of HIV-1, are extracted from a database of, in silico d...
An active analog approach to receptor mapping was used to identify the three dimensional structural ...
The human immunodeficiency virus (HIV) is currently ranked sixth in the worldwide causes of death [1...
6-Arylthio-3-hydroxypyrimidine-2,4-diones inhibit the activities of human immunodeficiency virus rib...
HIV-1 reverse transcriptase (HIV-1 RT) plays an important role in the duplication of HIV-1. It has b...
As a key component in combination therapy for acquired immunodeficiency syndrome (AIDS), non-nucleos...
In this work we report a parallel application of both docking- and shape-based virtual screening (VS...
Human immunodeficiency virus (HIV) is the primary infectious agent of acquired immunodeficiency synd...
AbstractDue to the AIDS crisis, development of new, selective and safe non-nucleoside reverse transc...
A selection of 289 pyrimidine derivatives with anti-HIV RT activities as non-nucleoside HIV RT inhib...
© 2015 Elsevier B.V. A selection of 289 pyrimidine derivatives with anti-HIV RT activities as non-nu...
The Acquired Immunodeficiency Syndrome (AIDS) is one the most fatal disorders for which there have b...
Diarylpyrimidines (DAPYs), acting as HIV-1 nonnucleoside reverse transcriptase inhibitors (NNRTIs), ...
There has been a tremendous progress in the development of anti-HIV therapies since the discovery of...
1484-1493Seven novel lead compounds, acting as NNRTIs of HIV-1, are extracted from a database of, in...
Seven novel lead compounds, acting as NNRTIs of HIV-1, are extracted from a database of, in silico d...
An active analog approach to receptor mapping was used to identify the three dimensional structural ...
The human immunodeficiency virus (HIV) is currently ranked sixth in the worldwide causes of death [1...
6-Arylthio-3-hydroxypyrimidine-2,4-diones inhibit the activities of human immunodeficiency virus rib...
HIV-1 reverse transcriptase (HIV-1 RT) plays an important role in the duplication of HIV-1. It has b...
As a key component in combination therapy for acquired immunodeficiency syndrome (AIDS), non-nucleos...
In this work we report a parallel application of both docking- and shape-based virtual screening (VS...
Human immunodeficiency virus (HIV) is the primary infectious agent of acquired immunodeficiency synd...
AbstractDue to the AIDS crisis, development of new, selective and safe non-nucleoside reverse transc...